MySize Publishes 2025 Shareholder Letter

Reuters03-04
MySize Publishes 2025 Shareholder Letter

MySize, Inc. filed a Form 8-K that includes a letter to stockholders from Chief Executive Officer Ronen Luzon. The letter states that Nasdaq notified MySize, Inc. on March 2, 2026 that the company’s common stock closing bid price had been below $1.00 for 30 consecutive trading days, and that Nasdaq provided a compliance period until August 31, 2026. The letter says the notice does not affect operations and that MySize, Inc. intends to regain compliance, including by monitoring the bid price and considering options under Nasdaq listing rules. The letter also references 2025 revenue figures and margin information for certain business units, and provides management estimates for potential annual revenue for 10peaks. The full letter can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. My Size Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-008720), on March 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment